Global University Venturing

The number of corporate-backed companies going public declined in 2019, despite some major IPOs like those of Uber, Lyft and Slack.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The CNS disease drug developer has raised funding in a GV-backed round just four months after it emerged from UT Southwestern with $30m.

Osage University Partners backed a round for Aerovate Therapeutics that will go to testing an inhaled version of the latter's pulmonary disease therapy.

Osage University Partners has returned to bring the big urban transit data analytics company's funding total to more than $40m.

GV and Decibel co-led the round having previously backed the U-M networking cybersecurity company alongside Greylock Partners in 2016.

Wenge Tech, a CAS-owned data analytics business targeting media applications, has attracted Cash Holdings and CAS Star for its latest round.

Cigna and Kaiser Permanente have participated in a $50m series D round for Ginger, bringing the MIT spinout's total funding to more than $120m.

UCL's Freeline Therapeutics has priced its shares at $18 to raise nearly $159m through an IPO on the Nasdaq Global Select Market.

Fujita, Industrial Growth Platform and SBI were among the investors in the automation technology developer, a spinout of University of Tokyo.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.